Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1177127

registered interest
date	07/02/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Suicide: Gambling
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to establish a publicly accessible central record of the number of people who commit suicide for reasons connected with problem gambling.
tabling member printed	The Lord Bishop of St Albans
uin	HL1452
answer	answer is ministerial correction date of answer 13/02/2020 answer text <p>We presently have no such plans. There is currently no reliable estimate of the number of suicides linked to gambling addiction or problem gambling in the United Kingdom. The Government is committed to improving our understanding of the link between suicide and gambling.</p><p>GambleAware has commissioned some preliminary research into gambling-related suicide, which was published in July 2019, and the Department has invited GambleAware to return to the National Suicide Prevention Strategy Advisory Group to discuss the research findings and what further research may be needed in this area.</p> answering member printed Baroness Blackwood of North Oxford question first answered 13/02/2020 14:51:51 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4308 label Biography information for The Lord Bishop of St Albans

1175375

registered interest
date	30/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Minimum Prices
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the response by Baroness Williams of Trafford on 21 January (HL Deb, col 1043), what instructions they have given Public Health England about monitoring and assessing the efficacy of minimum unit pricing in Scotland; and when will Public Health England be reporting any such findings.
tabling member printed	Lord Brooke of Alverthorpe
uin	HL1189
answer	answer is ministerial correction date of answer 12/02/2020 answer text <p>Public Health England have not been formally commissioned to undertake a review of the evidence of Minimum Unit Pricing (MUP) in Scotland. However, as part of their role in gathering evidence across areas to feed into the policy making process they are monitoring progress of MUP in Scotland and working closely with partners there to understand the impact of the policy. The Scottish Government is taking forward a comprehensive evaluation of the impact of introducing MUP. The Scottish legislation also includes a sunset clause and the Scottish Government are required to present a report on the impact of MUP to their Parliament five years after implementation. which will be published in 2023.</p> answering member printed Baroness Blackwood of North Oxford question first answered 12/02/2020 17:42:48 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3335 label Biography information for Lord Brooke of Alverthorpe

1174116

registered interest
date	28/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services: Contracts
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many contracts were handed back to local authorities in England in the financial years (1) 2017/18, (2) 2018/19, and (3) 2019/20 by (a) nursing homes, (b) residential care homes, and (c) domiciliary care organisations; and which local authorities were involved.
tabling member printed	Lord Warner
uin	HL887
answer	answer is ministerial correction date of answer 06/02/2020 answer text <p>This information is not collected centrally.</p> answering member printed Baroness Blackwood of North Oxford question first answered 06/02/2020 17:24:08 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1732 label Biography information for Lord Warner

1175306

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pregnancy: Carbon Monoxide
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government how many non-smoking pregnant women, who have their carbon monoxide levels routinely monitored, have been found to have raised levels of carbon monoxide.
tabling member printed	Baroness Finlay of Llandaff
uin	HL791
answer	answer is ministerial correction date of answer 05/02/2020 answer text <p>This information is not held centrally.</p> answering member printed Baroness Blackwood of North Oxford question first answered 05/02/2020 16:19:54 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3609 label Biography information for Baroness Finlay of Llandaff

1175307

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Amazon
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 21 January (HL127), how they intend to assess (1) how any potential for Alexa to help with "prevention and early diagnosis" is being delivered in practice; and (2) whether such an approach is within the broader public interest.
tabling member printed	Lord Hunt of Kings Heath
uin	HL792
answer	answer is ministerial correction date of answer 06/02/2020 answer text <p>The agreement with Amazon to provide medically verified National Health Service information from the NHS website, through its voice assistant Alexa, will help people become more informed about a range of medical conditions, their symptoms, and their potential treatments. Greater access to that information from the NHS will help people manage their own healthcare more effectively, reaching a far greater number of United Kingdom citizens, which could help with prevention and early diagnosis.</p><p> </p><p>Significantly, it will help those who rely on voice-activated technology, such as elderly people or blind and visually impaired people, to access expert, accurate and safe medical information from the NHS.</p> answering member printed Baroness Blackwood of North Oxford question first answered 06/02/2020 17:24:56 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1175308

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Negligence
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 22 January (HL258), whether they can provide the information set out in Figure 3 on page 37 of the NHS Resolution Annual report and accounts 2018/19, published on 11 July 2019, in respect of clinical negligence cases only.
tabling member printed	Lord Hunt of Kings Heath
uin	HL793
answer	answer is ministerial correction date of answer 06/02/2020 answer text <p>NHS Resolution handles clinical negligence claims on behalf of National Health Service organisations and independent sector providers of NHS care in England.</p><p>The following table shows settled clinical negligence claims in financial years 2017/18 and 2018/19.</p><table><tbody><tr><td><p>Financial Year</p></td><td><p>Settlement Type</p></td><td><p>Number of claims settled with damages</p></td><td><p>Number of claims settled with no damages</p></td><td><p>% damages</p></td><td><p>% No damages</p></td></tr><tr><td><p>2017/18</p></td><td><p>No proceedings</p></td><td><p>3,932</p></td><td><p>4,119</p></td><td><p>3,932 (33.1%)</p></td><td><p>4,119 (34.6%)</p></td></tr><tr><td><p>2018/19</p></td><td><p>No proceedings</p></td><td><p>4,015</p></td><td><p>3,858</p></td><td><p>4,015 (35.2%)</p></td><td><p>3,858 (33.8%)</p></td></tr><tr><td><p>2017/18</p></td><td><p>Proceedings</p></td><td><p>2,989</p></td><td><p>780</p></td><td><p>2,989 (25.1%)</p></td><td><p>780 (6.6%)</p></td></tr><tr><td><p>2018/19</p></td><td><p>Proceedings</p></td><td><p>2,872</p></td><td><p>615</p></td><td><p>2,872 (25.2%)</p></td><td><p>615 (5.4%)</p></td></tr><tr><td><p>2017/18</p></td><td><p>Trial</p></td><td><p>28</p></td><td><p>48</p></td><td><p>28 (0.2%)</p></td><td><p>48 (0.4%)</p></td></tr><tr><td><p>2018/19</p></td><td><p>Trial</p></td><td><p>22</p></td><td><p>35</p></td><td><p>22 (0.2%)</p></td><td><p>35 (0.3%)</p></td></tr></tbody></table><p> </p><p><em>Note: </em></p><p>The percentage figures in the table may not add to exactly 100% due to rounding.</p> answering member printed Baroness Blackwood of North Oxford question first answered 06/02/2020 11:25:47 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1175309

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what assessment they have made of (1) the extent, and (2) the range, of drug shortages in the NHS.
tabling member printed	Lord Hunt of Kings Heath
uin	HL794
answer	answer is ministerial correction date of answer 06/02/2020 answer text <p>The majority of medicines are dispensed in England every day without issue, with over two million prescription items dispensed each day. However, the production of medicines is complex and highly regulated, and materials and processes must meet rigorous safety and quality standards. Supply problems can affect a wide range of drugs and can arise for various reasons, such as manufacturing issues, problems with the raw ingredients and batch failures.</p><p>The Department has well established processes to manage and mitigate supply problems that may arise at any one time and works closely with the Medicines and Healthcare Regulatory Authority (MHRA), the pharmaceutical industry, NHS England and NHS Improvement and others operating in the supply chain, to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p>Where issues do arise, the Department will use a host of tools which might include working with the MHRA to expedite regulatory procedures, working with manufacturers to manage remaining supplies and expedite the delivery of further stock and commissioning clinical advice on alternative options from specialist clinicians.</p><p>Furthermore, the team routinely works with specialist importer companies to obtain unlicensed products from abroad to help to manage supply issues affecting the National Health Service.</p><p>Occasionally the team will work with wholesalers and suppliers to put demand management processes in place to ensure the equitable distribution of stock throughout the country as this ensures the NHS can continue to access the medicines it requires.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL795 HL796 HL797 question first answered 06/02/2020 17:22:55 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1175310

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what assessment they have made of the causes of drug shortages in the NHS.
tabling member printed	Lord Hunt of Kings Heath
uin	HL795
answer	answer is ministerial correction date of answer 06/02/2020 answer text <p>The majority of medicines are dispensed in England every day without issue, with over two million prescription items dispensed each day. However, the production of medicines is complex and highly regulated, and materials and processes must meet rigorous safety and quality standards. Supply problems can affect a wide range of drugs and can arise for various reasons, such as manufacturing issues, problems with the raw ingredients and batch failures.</p><p>The Department has well established processes to manage and mitigate supply problems that may arise at any one time and works closely with the Medicines and Healthcare Regulatory Authority (MHRA), the pharmaceutical industry, NHS England and NHS Improvement and others operating in the supply chain, to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p>Where issues do arise, the Department will use a host of tools which might include working with the MHRA to expedite regulatory procedures, working with manufacturers to manage remaining supplies and expedite the delivery of further stock and commissioning clinical advice on alternative options from specialist clinicians.</p><p>Furthermore, the team routinely works with specialist importer companies to obtain unlicensed products from abroad to help to manage supply issues affecting the National Health Service.</p><p>Occasionally the team will work with wholesalers and suppliers to put demand management processes in place to ensure the equitable distribution of stock throughout the country as this ensures the NHS can continue to access the medicines it requires.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL794 HL796 HL797 question first answered 06/02/2020 17:22:55 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1175311

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government what prioritisation process is used by the NHS for the rationing of essential drugs in cases when there is a shortage of such drugs.
tabling member printed	Lord Hunt of Kings Heath
uin	HL796
answer	answer is ministerial correction date of answer 06/02/2020 answer text <p>The majority of medicines are dispensed in England every day without issue, with over two million prescription items dispensed each day. However, the production of medicines is complex and highly regulated, and materials and processes must meet rigorous safety and quality standards. Supply problems can affect a wide range of drugs and can arise for various reasons, such as manufacturing issues, problems with the raw ingredients and batch failures.</p><p>The Department has well established processes to manage and mitigate supply problems that may arise at any one time and works closely with the Medicines and Healthcare Regulatory Authority (MHRA), the pharmaceutical industry, NHS England and NHS Improvement and others operating in the supply chain, to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p>Where issues do arise, the Department will use a host of tools which might include working with the MHRA to expedite regulatory procedures, working with manufacturers to manage remaining supplies and expedite the delivery of further stock and commissioning clinical advice on alternative options from specialist clinicians.</p><p>Furthermore, the team routinely works with specialist importer companies to obtain unlicensed products from abroad to help to manage supply issues affecting the National Health Service.</p><p>Occasionally the team will work with wholesalers and suppliers to put demand management processes in place to ensure the equitable distribution of stock throughout the country as this ensures the NHS can continue to access the medicines it requires.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL794 HL795 HL797 question first answered 06/02/2020 17:22:55 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1175312

registered interest
date	27/01/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	Her Majesty's Government whether unlicensed medicines are used to help with any shortages of drug supply in the NHS; and if so, how many.
tabling member printed	Lord Hunt of Kings Heath
uin	HL797
answer	answer is ministerial correction date of answer 06/02/2020 answer text <p>The majority of medicines are dispensed in England every day without issue, with over two million prescription items dispensed each day. However, the production of medicines is complex and highly regulated, and materials and processes must meet rigorous safety and quality standards. Supply problems can affect a wide range of drugs and can arise for various reasons, such as manufacturing issues, problems with the raw ingredients and batch failures.</p><p>The Department has well established processes to manage and mitigate supply problems that may arise at any one time and works closely with the Medicines and Healthcare Regulatory Authority (MHRA), the pharmaceutical industry, NHS England and NHS Improvement and others operating in the supply chain, to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p>Where issues do arise, the Department will use a host of tools which might include working with the MHRA to expedite regulatory procedures, working with manufacturers to manage remaining supplies and expedite the delivery of further stock and commissioning clinical advice on alternative options from specialist clinicians.</p><p>Furthermore, the team routinely works with specialist importer companies to obtain unlicensed products from abroad to help to manage supply issues affecting the National Health Service.</p><p>Occasionally the team will work with wholesalers and suppliers to put demand management processes in place to ensure the equitable distribution of stock throughout the country as this ensures the NHS can continue to access the medicines it requires.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL794 HL795 HL796 question first answered 06/02/2020 17:22:55 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath